Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Ritu Baral lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $35.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
